Navigation Links
Cepheid Reports Fourth Quarter and Full Year 2010 Results
Date:1/27/2011

931,6536,8068,200Research and development

11,6669,91642,50339,313Sales and marketing

10,6268,38738,84029,156General and administrative

6,9325,44624,52821,278Gain from legal settlement

———(243)Restructuring charge8212;8212;8212;747Total costs and operating expenses

56,88753,239217,812193,993Income (loss) from operations

1,839(4,035)(5,344)(23,366)Other income (expense), net

(346)(223)(992)424Income (loss) before benefit (provision) for income taxes

1,493(4,258)(6,336)(22,942)Benefit (provision) for income taxes

(148)(24)419440Net income (loss)

$
,345$   (4,282)$   (5,917)$  (22,502)Basic net income (loss) per share

$
.02$
(0.07)$
(0.10)$
(0.39)Diluted net income (loss) per share

$
.02$
(0.07)$
(0.10)$
(0.39)Shares used in computing basic net income (loss) per share

60,41358,596

SOURCE Cepheid
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
2. Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
3. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
4. Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
5. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
6. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
7. Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
8. Cepheid Reports 2009 Third Quarter Results
9. Cepheid to Webcast Upcoming Financial Presentations
10. Cepheid Collaborates With Pharmaceutical Leader on Chronic Myelogenous Leukemia
11. Cepheid to Webcast Upcoming Financial Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 24 de mayo de 2013  Volcano Corporation ... y fabricante de herramientas de precisión para terapia ... de la enfermedad vascular periférica y coronaria, anunció ... Ad enosine V asodilator I ndependent ... la sesión de ensayo clínico hot line late ...
(Date:5/23/2013)... 2013 Amgen (NASDAQ: AMGN ) will ... Conference on Thursday, May 30, 2013, at the Westin Boston ... a.m. Eastern Daylight Time. Arvind Sood , ... the conference. Live audio of the presentation can be accessed ... under Investors. A replay of the webcast will also be ...
(Date:5/23/2013)... RIVER EDGE, N.J. , May 23, 2013 /PRNewswire/ ... ), a commercial stage medical device company that develops ... the successful completion of its rights offering.  In addition, ... company,s March 2011 warrants expired on May 17, 2013. ... proceeds of $3.0 million from the rights offering.   A ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... , April 23, 2010 , , , ... A Migraine For Pharma Forecasters , , , ... up,s and down,s, with new markets,and products proving more complex and requiring sophisticated approaches to,forecast these areas. ... Dealing with uncertainties is no easy task. With a number ...
... TOKYO , April 23 Astellas Pharma Inc. (TSE: ... $52 per share for all of the currently outstanding shares ... Inc. (Nasdaq: OSIP ) to 5:00 p.m. New ... further extended.  The tender offer was previously set to expire at 12:00 ...
Cached Medicine Technology:MarketsandMarkets Partners With Eyeforpharma For The Pharma Forecasting Excellence Europe 2010 Summit 2MarketsandMarkets Partners With Eyeforpharma For The Pharma Forecasting Excellence Europe 2010 Summit 3Expiration Date of OSI Offer Extended to May 17, 2010 2Expiration Date of OSI Offer Extended to May 17, 2010 3Expiration Date of OSI Offer Extended to May 17, 2010 4
(Date:5/25/2013)... Mansfield, MA (PRWEB) May 25, 2013 Imagine ... long -- the energy loss, hot air and wasted energy! ... whole house fan, a fireplace or clothes dryer, that may ... , Drafts from these often overlooked holes waste energy in ... source of heating and cooling loss in the home. , ...
(Date:5/25/2013)... May 25, 2013 Life science and ... used to detect and create a new substance with ... and are also known as biotechnology reagents. Such reagents ... and education. , This market is driven by factors ... the field of therapeutics, growth in research and rapid ...
(Date:5/25/2013)... -- Animals make great companions for senior citizens, but elderly ... are far more likely to crash than those who never ... study included 2,000 licensed drivers aged 70 and older. The ... they drove with their pet in the car. Among ... was twice as high as among those who never drove ...
(Date:5/25/2013)... Sun City Center, FL (PRWEB) May 25, 2013 ... years, is one of many of the NALA’s businesses throughout ... Owner, Craig Amshel chose to participate in the nationwide event ... served as a Lieutenant Colonel in the Army. He said, ... work in the community I serve, but I live here ...
(Date:5/25/2013)... 25, 2013 On May 25, Voices ... research and advocacy, comments on a new study by ... incorporating cold atmospheric plasma into brain cancer treatment may ... to a Science Daily article, physicists from ... and physicians demonstrated the “synergistic effect of cold atmospheric ...
Breaking Medicine News(10 mins):Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2
... Pavilion Offers Unique Skills Training Where Patients, Replicate Real-World ... ... Personal Support, LOMA LINDA, Calif., ... Empire,s leader in physical,rehabilitation for survivors of stroke, fractures, amputations, ...
... 2008) MIT graduate student and synthetic biologist ... pose threats to human health. His current mission: ... M.D. candidate and Ph.D. in the Harvard-MIT Division ... $30,000 Lemelson-MIT Student Prize for inventing processes that ...
... association of ABG with thyroid disorders (TD) was first ... the association between Pernicious Anemia (PA) and Thyroiditis on ... recently systematic studies have focused on this frequently overlooked ... January 28, 2008 in the World Journal of Gastroenterology ...
... to Host Conference Call on Tuesday, March 4th at 2:00 ... Hooper Holmes,Inc. (Amex: HH ) today announced that it ... Tuesday, March 4th at 2:00 pm ET. The,Company,s newly- appointed ... the call., The focus of the conference call will ...
... the findings , , TUESDAY, Feb. 26 (HealthDay News) -- ... for people with varying degrees of depression, the drugs ... depression, a new study suggests. , "Although patients get ... when they take a placebo, and the difference in ...
... YORK, Feb. 27 American Oriental,Bioengineering, Inc. (NYSE: ... and nutraceutical products, today announced that,it plans to release ... morning of Thursday, March 6, 2008 before the market ... that morning at 8:00 am ET to,discuss results. Listeners ...
Cached Medicine News:Health News:Loma Linda University Medical Center Celebrates Groundbreaking on Inland Empire's Most Comprehensive Rehabilitation Center 2Health News:Loma Linda University Medical Center Celebrates Groundbreaking on Inland Empire's Most Comprehensive Rehabilitation Center 3Health News:Bacteria beware: MIT student invents knock-out punch for antibiotic resistance 2Health News:Bacteria beware: MIT student invents knock-out punch for antibiotic resistance 3Health News:Bacteria beware: MIT student invents knock-out punch for antibiotic resistance 4Health News:Does artificial intelligence help clinicians to recognize atrophic gastritis with thyroid disease? 2Health News:Hooper Holmes to Provide Business Update 2Health News:Only Severely Depressed Benefit From Antidepressants: Study 2Health News:American Oriental Bioengineering to Report Fourth Quarter and Full Year 2007 Financial Results 2
Primary and Posterior Stabilized Components....
... knee prosthesis stems from many years of ... manufacturing technologies have been used in order ... as a favorable pressure distribution pattern on ... to a minimum. The inherent design of ...
... The Natural Knee design ... a proprietary CSTi porous coating ... active patients, a unique bone ... deepened trochlear groove to maximize ...
Advance Posterior Stabilized Total Knee systems improves patellofemoral kinematics, reduces wear rate potential, increases resistance to posterior tibial dislocation, achieves at least 120o flexion i...
Medicine Products: